Skip to main content
SpringerLink
Log in

Controlled Clinical Trials in Neurological Disease

  • Book
  • © 1990

Overview

Editors:
  1. Roger J. Porter

    1. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Bruce S. Schoenberg

    1. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Foundations of Neurology (FONY, volume 1)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (25 chapters)

  1. Front Matter

    Pages i-xxiii
    Download chapter PDF

  2. Design of Controlled Clinical Trials

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Clinical Considerations

      • John F. Kurtzke
      Pages 3-16

    3. Initial Statistical Considerations

      • B. G. White
      Pages 17-27

    4. Statistical and Epidemiological Considerations

      • James M. Dambrosia
      Pages 29-51

  3. Implementation and Interpretations of Controlled Clinical Trials (Example: Epilepsy)

    1. Front Matter

      Pages 53-53
      Download chapter PDF

    2. Perspective of the Patient

      • Nancy Santilli
      Pages 55-62

    3. Perspective of the Participating Investigator

      • Fritz E. Dreifuss, Nancy Santilli
      Pages 63-68

    4. Perspective of the Clinical Center

      • Nancy Santilli
      Pages 69-76

    5. Perspective of the Coordinating Center

      • James J. Cereghino
      Pages 77-83

    6. Perspective of the Food and Drug Administration

      • Russell Katz
      Pages 85-96

    7. Perspective of the Pharmaceutical Industry

      • Lynn D. Kramer, James L. Perhach
      Pages 97-104

    8. Perspective of the Insurance Industry

      • Lawrence C. Morris
      Pages 105-110

  4. Applications of Controlled Clinical Trials to Diseases of the Nervous System

    1. Front Matter

      Pages 111-111
      Download chapter PDF

    2. Cerebrovascular Disease

      • Michel A. Beaudry, Vladimir C. Hachinski
      Pages 113-132

    3. Epilepsy

      • Roger J. Porter
      Pages 133-155

    4. Movement Disorders

      • Lawrence I. Golbe, Roger C. Duvoisin
      Pages 157-170

    5. Head and Spinal Cord Injury

      • Howard M. Eisenberg
      Pages 171-183

    6. Headache

      • Jes Olesen, Peer Tfelt-Hansen
      Pages 185-201

    7. Peripheral Neuropathy

      • Peter James Dyck, Peter O’brien
      Pages 203-224
Back to top

Keywords

About this book

The evaluation of the efficacy and safety of a clinical tool, be it a diagnostic technique, a preventive methodology, or a therapeutic intervention, is an im­ portant responsibility of physicians. The history of medicine is characterized by the authoritarianisms of teachers and of organizations giving way to the clinical experience of physicians; authoritarian dictum was replaced by case report and then by case series. As physicians learned to substitute the analysis of data for the inconsistencies of dictums and anecdotes, the problems of the case series as an investigative tool became more evident: patient selection criteria, measurements of outcome, significance of results, and extrapolation of conclusions to the community of patients. In response to these issues, the methodology of the controlled clinical trial has evolved and with it the instru­ ments of study design and of biostatistics as aids to study design and data analysis. The medical - surgical armamentarium has evolved from being dependent solely upon the observations and conclusions of a skilled clinician to being constructed upon the systematic collection and evaluation of data by a team of skilled clinicians and their statistical colleagues: this is the controlled clinical trial. During the past two decades, the evaluation of clinical approaches to pre­ vention and therapy has become particularly important to clinicians concerned with nervous system dysfunction. There has been and continues to be an explosion of information from the basic neurosciences and from the applica­ tion of biotechnology to the nervous system.

Reviews

`Cet ouvrage, rédigée par de nombreux experts et d'une manière fort critique, est certainement très précieux. Il mérite d'être lu et médité.'
Acta Neurologica, 90, 1990

` ... for any serious researcher. The book is recommended for all health care professionals who have an interest in neurological neurosurgical or neurorehabilitative research.'
Brain Injury, 7:1

Editors and Affiliations

  • National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA

    Roger J. Porter, Bruce S. Schoenberg

Bibliographic Information

  • Book Title: Controlled Clinical Trials in Neurological Disease

  • Editors: Roger J. Porter, Bruce S. Schoenberg

  • Series Title: Foundations of Neurology

  • DOI: https://doi.org/10.1007/978-1-4613-1495-0

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Kluwer Academic Publishers 1990

  • Hardcover ISBN: 978-0-7923-0613-9Published: 31 May 1990

  • Softcover ISBN: 978-1-4612-8804-6Published: 01 October 2011

  • eBook ISBN: 978-1-4613-1495-0Published: 06 December 2012

  • Series ISSN: 0924-8935

  • Edition Number: 1

  • Number of Pages: XXIV, 440

  • Topics: Neurology, Neurosciences

Publish with us

Policies and ethics

Back to top

Search

Navigation